| David John Whitmore, DO | |
|
1301 Hal Greer Blvd, Huntington, WV 25701 | |
| (304) 525-0572 | |
| Not Available |
| Full Name | David John Whitmore |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 1301 Hal Greer Blvd, Huntington, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275511404 | NPI | - | NPPES |
| 64025802 | Medicaid | KY | |
| 5630298000 | Medicaid | WV | |
| 930102983 | Other | RAILROAD | |
| 00218366 | Other | WV | RR MEDICARE |
| 2159006 | Medicaid | OH | |
| 000000204091 | Other | KY | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 02693 (Kentucky) | Secondary |
| 207Q00000X | Family Medicine | 02693 (Kentucky) | Secondary |
| 207Q00000X | Family Medicine | 1674 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Home Health Service | Huntington, WV | Home health agency |
| Cabell Huntington Hospital Inc | Huntington, WV | Hospital |
| St Mary's Medical Center | Huntington, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Health Systems, Inc | 9931017969 | 53 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
Men who suffer from obstructive sleep apnea (OSA) are seeing another potential benefit from continuous positive airway pressure therapy, or CPAP: improved sexual function and satisfaction in non-diabetic men under age 60.
La Fontaine will be opening December 2015. This development will be the fourteenth property in the company's expanding portfolio.
Results from a small study of intractable pain patients being treated with the human chorionic gonadotropin (HCG) hormone reported that they had experienced pain free hours in the past month. These results were presented at a poster session at the American Academy of Pain Medicine's 27th Annual Meeting.
› Verified 9 days ago
| Entity Name | Valley Health Systems, Inc |
|---|---|
| Entity Type | Part B Supplier - Public Health/welfare Agency |
| Entity Identifiers | NPI Number: 1902962368 PECOS PAC ID: 9931017969 Enrollment ID: O20040325000411 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
Men who suffer from obstructive sleep apnea (OSA) are seeing another potential benefit from continuous positive airway pressure therapy, or CPAP: improved sexual function and satisfaction in non-diabetic men under age 60.
La Fontaine will be opening December 2015. This development will be the fourteenth property in the company's expanding portfolio.
Results from a small study of intractable pain patients being treated with the human chorionic gonadotropin (HCG) hormone reported that they had experienced pain free hours in the past month. These results were presented at a poster session at the American Academy of Pain Medicine's 27th Annual Meeting.
› Verified 9 days ago
| Entity Name | Valley Health Systems, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902962368 PECOS PAC ID: 9931017969 Enrollment ID: O20040325000570 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
Men who suffer from obstructive sleep apnea (OSA) are seeing another potential benefit from continuous positive airway pressure therapy, or CPAP: improved sexual function and satisfaction in non-diabetic men under age 60.
La Fontaine will be opening December 2015. This development will be the fourteenth property in the company's expanding portfolio.
Results from a small study of intractable pain patients being treated with the human chorionic gonadotropin (HCG) hormone reported that they had experienced pain free hours in the past month. These results were presented at a poster session at the American Academy of Pain Medicine's 27th Annual Meeting.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David John Whitmore, DO Po Box 1680, Huntington, WV 25717-1680 Ph: (304) 697-1396 | David John Whitmore, DO 1301 Hal Greer Blvd, Huntington, WV 25701 Ph: (304) 525-0572 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
Men who suffer from obstructive sleep apnea (OSA) are seeing another potential benefit from continuous positive airway pressure therapy, or CPAP: improved sexual function and satisfaction in non-diabetic men under age 60.
La Fontaine will be opening December 2015. This development will be the fourteenth property in the company's expanding portfolio.
Results from a small study of intractable pain patients being treated with the human chorionic gonadotropin (HCG) hormone reported that they had experienced pain free hours in the past month. These results were presented at a poster session at the American Academy of Pain Medicine's 27th Annual Meeting.
› Verified 9 days ago
Jessica D Wilson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 Valley Drive, Huntington, WV 25702 Phone: 304-675-4340 | |
Katherine Steele, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Dr, Suite 1500, Huntington, WV 25701 Phone: 304-691-1100 Fax: 304-691-1153 | |
Carrie Marie Dillard, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Hal Greer Blvd, Huntington, WV 25701 Phone: 304-526-2319 Fax: 304-526-2420 | |
Janet Nease Wallace, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 1st Ave, Opc Suite 30, Huntington, WV 25702 Phone: 304-399-7280 Fax: 304-399-7282 | |
Scott W Mitchell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Hal Greer Blvd, Huntington, WV 25701 Phone: 304-399-6515 Fax: 304-399-6667 | |
Deidre E Parsley, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2900 First Avenue, Huntington, WV 25702 Phone: 304-399-7484 Fax: 304-399-7579 | |
Adam M Franks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Dr, Suite 1500, Huntington, WV 25701 Phone: 304-691-1100 Fax: 304-691-1183 |